Tighter coverage restrictions certain for costly treatments.

BLUE Shield of California Life & Health Insurance Co.; BREAST cancer treatment; HEALTH insurance reimbursement; UNITED States. Food & Drug Administration; VOGENBERG, Randy

The article reports that the Blue Shield of California states that it will no longer pay for the use of Avastin to treat metastatic breast cancer. Randy Vogenberg, principal at the Institute for Integrated Healthcare, states that more restrictions can follow in the areas of medical care once reimbursement changes in health insurance benefits occur. The author mentions that Blue Shield is the first to end payments since U.S. Food and Drug Administration (FDA) withdraw its approval for the drug.